Literature DB >> 1538726

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.

R C Hubbard1, N G McElvaney, P Birrer, S Shak, W W Robinson, C Jolley, M Wu, M S Chernick, R G Crystal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538726     DOI: 10.1056/NEJM199203193261207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  47 in total

1.  Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

Authors:  C R Scriver; T M Fujiwara
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

2.  Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.

Authors:  E Sadeghi; A Matlow; I MacLusky; M A Karmali
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

Review 3.  Recent advances in cystic fibrosis.

Authors:  G Santis; D Geddes
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

Review 4.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

5.  Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?

Authors:  S P Conway
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 6.  Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.

Authors:  D A Spencer
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 7.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

8.  Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses.

Authors:  Y S Lie; E M Penuel; M A Low; T P Nguyen; J O Mangahas; K P Anderson; C J Petropoulos
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 9.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

10.  An alternative aerosol delivery system for amiloride.

Authors:  M L Everard; S G Devadason; V B Sunderland; P N Le Souef
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.